[DOI] [PMC free article] [PubMed] [Google Scholar] 74.Kim ER, et al
Yet, tirzepatide appears to be superior for glycemic control in T2D patients
53 Furthermore, observational and clinical studies indicate postmenopausal hormone replacement therapy is associated with lower liver enzyme levels, protection against metabolic dysfunction, and lower risk of NAFLD
Front Physiol 15:1346173 Bratosin D, Estaquier J, Petit F et al (2001) Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria
Both are high-weight HHS-HCC categories due to extreme resource utilization
Sources Vukojevi, J., et al